Comera Life Sciences Stock Fundamentals
Comera Life Sciences fundamentals help investors to digest information that contributes to Comera Life's financial success or failures. It also enables traders to predict the movement of Comera Pink Sheet. The fundamental analysis module provides a way to measure Comera Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Comera Life pink sheet.
Comera |
Comera Life Sciences Company Current Valuation Analysis
Comera Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Comera Life Current Valuation | 9.96 M |
Most of Comera Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Comera Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Comera Life Sciences has a Current Valuation of 9.96 M. This is 99.93% lower than that of the Biotechnology sector and 99.79% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.94% higher than that of the company.
Comera Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Comera Life's current stock value. Our valuation model uses many indicators to compare Comera Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Comera Life competition to find correlations between indicators driving Comera Life's intrinsic value. More Info.Comera Life Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Comera Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Comera Life's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Comera Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Comera Life's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Comera Life could also be used in its relative valuation, which is a method of valuing Comera Life by comparing valuation metrics of similar companies.Comera Life is currently under evaluation in current valuation category among its peers.
Comera Fundamentals
| Return On Equity | -16.29 | |||
| Return On Asset | -1.19 | |||
| Operating Margin | (15.82) % | |||
| Current Valuation | 9.96 M | |||
| Shares Outstanding | 30.74 M | |||
| Shares Owned By Insiders | 51.33 % | |||
| Shares Owned By Institutions | 2.70 % | |||
| Number Of Shares Shorted | 281.55 K | |||
| Price To Sales | 43.28 X | |||
| Revenue | 633.1 K | |||
| Gross Profit | 422.71 K | |||
| EBITDA | (13.33 M) | |||
| Net Income | (18 M) | |||
| Cash And Equivalents | 4.94 M | |||
| Cash Per Share | 0.26 X | |||
| Total Debt | 775.05 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 2.14 X | |||
| Book Value Per Share | (0.14) X | |||
| Cash Flow From Operations | (9.77 M) | |||
| Short Ratio | 0.84 X | |||
| Earnings Per Share | (0.22) X | |||
| Number Of Employees | 12 | |||
| Beta | 1.16 | |||
| Market Capitalization | 6.85 M | |||
| Total Asset | 3.73 M | |||
| Retained Earnings | (34.9 M) | |||
| Working Capital | (2 M) | |||
| Z Score | -20.09 | |||
| Net Asset | 3.73 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Comera Pink Sheet
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |